“High-probability” ventilation/perfusion (V˙/Q˙) lung scans generally indicate proximal pulmonary arterial occlusion by thromboemboli or, rarely, other processes such as tumors, fibrosing mediastinitis, or vasculitis. In this report we describe three patients with high probability V˙/Q˙ scans in whom pulmonary angiography failed to demonstrate arterial occlusion. All three patients were determined to have pulmonary venoocclusive disease (PVOD). In two patients, a tissue diagnosis of PVOD was made, in one case with explanted tissue taken after a successful heart–lung transplant and in the other case with tissue taken at autopsy. PVOD in the third patient was diagnosed with pulmonary venography. A potential explanation for the discrepancy between perfusion lung scan and pulmonary angiographic findings in PVOD is discussed.
Ventilation/perfusion (V˙/Q˙) lung scanning is an integral part of the evaluation of a patient with pulmonary hypertension (1). Multiple segmental perfusion defects usually indicate proximal thromboemboli as the cause of pulmonary hypertension (2). Rarely, a “high-probability” V˙/Q˙ scan is caused by other processes obstructing the pulmonary arterial tree, such as fibrosing mediastinitis, pulmonary artery sarcoma, and vasculitis (3-5). In all of these processes, pulmonary arteriography and chest computed tomography (CT) will confirm the presence of proximal obstructing lesions.
In this paper we describe three patients in whom marked discrepancies were noted between findings on V˙/Q˙ scans and those in pulmonary arteriograms. Two of three patients had biopsy-proven pulmonary venoocclusive disease (PVOD) as the cause of pulmonary hypertension; the other patient had PVOD diagnosed by pulmonary venography. These cases emphasize the importance of considering alternative causes for a high-probability V˙/Q˙ scan when pulmonary angiography fails to disclose evidence of pulmonary thromboembolism.
A 47-yr–old male had been well until 1 yr before referral, when he presented with rapidly worsening dyspnea. As part of his initial evaluation, he underwent a V˙/Q˙ scan that revealed multiple mismatched segmental perfusion defects. An open-lung biopsy was performed because of progressive pulmonary infiltrates, and demonstrated pulmonary arteriopathy with tortuous, dilated pulmonary veins. Upon referral, the patient underwent a repeat V˙/Q˙ scan, which confirmed multiple mismatched segmental perfusion defects involving the right upper lobe, right lower lobe, lingula, and part of the left lower lobe (Figure 1). Cardiac catheterization disclosed a right atrial pressure (Pra) of 6 mm Hg and a pulmonary artery pressure (Ppa) of 85/35 mm Hg (mean: 60 mm Hg). The pulmonary capillary wedge pressure (Ppcw) was 8 mm Hg and 12 mm Hg in the right and left pulmonary arteries, respectively. The cardiac output (CO) was 5.0 L/min, and the pulmonary vascular resistance (Rpv) was 832 dynes · s/cm5. Pulmonary angiography, done according to standard technique with separate injections of 55 to 60 ml of contrast medium into each main pulmonary artery, showed smoothly tapering major branches, with peripheral pruning bilaterally (Figures 2A and 2B). In the late phase of the pulmonary arteriogram, the pulmonary veins were extremely narrowed throughout their course. A spiral CT revealed increased interstitial markings, a small left pleural effusion, thickening of the interlobar septa, and attenuated pulmonary veins bilaterally. The patient subsequently underwent heart–lung transplantation. Histologic examination of explanted tissue was diagnostic for PVOD.
A 34-yr–old man with a history of mild systemic hypertension was in good health until 4 mo before admission, when he developed dyspnea on exertion of insidious onset. The dyspnea progressed rapidly and the patient was admitted to a local hospital, where he was found to have evidence of pulmonary hypertension on echocardiography and segmental mismatched perfusion defects on V˙/Q˙ scanning. Over the following 2 mo the patient's condition deteriorated rapidly and he was referred to this center for evaluation for pulmonary thromboendarterectomy. A repeat V˙/Q˙ scan was remarkable for multiple segmental and subsegmental mismatched perfusion defects involving both lungs (Figure 3). A chest CT showed a mosaic perfusion pattern, eccentric pleural thickening, prominent hilar and mediastinal lymphadenopathy, and marked enlargement of the central pulmonary arteries. Cardiac catheterization showed a Pra of 4 mm Hg, Ppa of 90/34 mm Hg (mean: 57 mm Hg), Ppcw of 5 mm Hg, cardiac index (CI) of 3.2 L/min/m2, and Rpv of 1,291 dynes · s/cm5. No intracardiac shunt or anomalous pulmonary venous return was detected. Pulmonary angiography showed enlarged central pulmonary arteries and pruning of the vessels distally (Figures 4A and 4B). No thromboemboli were detected on angiography or angioscopy. Inhaled NO at 20 ppm was given for 10 min, and repeat hemodynamics showed a Pra of 0 mm Hg, Ppa of 57/24 mm Hg (mean: 38 mm Hg), Ppcw of 7 mm Hg, CI of 2.7 L/min/m2, and Rpv of 917 dynes · s/cm5. Over the following several days, the patient became increasingly hypoxemic and ultimately expired from cardiac failure. The results of autopsy confirmed the diagnosis of PVOD.
A 38-yr–old woman with a history of hypothyroidism was well until 5 yr before presentation to our center, when she developed dyspnea during a pregnancy and was treated for a presumptive pulmonary embolism. Three years later she noted worsening exertional dyspnea. Further evaluation at that time included a cardiac catheterization showing moderate pulmonary hypertension and pulmonary angiography showing no evidence of proximal thromboemboli. She had an acute pulmonary vasodilator response to 20 ppm of inhaled NO and subsequently began treatment with diltiazem. Over the next several months her dyspnea and hypoxemia worsened, and she was referred to our center for evaluation for possible pulmonary thromboendarterectomy. A V˙/Q˙ scan was remarkable for multiple segmental and subsegmental mismatched perfusion defects, most prominent in the right upper lobe and bilateral bases (Figure 5). Cardiac catheterization showed a Pra of 2 mm Hg, Ppa of 47/20 mm Hg (mean: 26 mm Hg), Ppcw of 7 mm Hg, CO of 5.34 L/min, and Rpv of 284 dynes · s/cm5. With exercise, the Ppa increased to 80/33 mm Hg (mean: 50 mm Hg). The Ppcw was 10 mm Hg, the Rpv was 334 dynes · s/cm5, and the CO was 9.58 L/min. Pulmonary angiography revealed significant peripheral pruning of the left-sided vessels and a minor irregularity at the takeoff of the right middle-lobe vessel, but no evidence of pulmonary thromboemboli (Figures 6A and 6B). Pulmonary angioscopy confirmed the absence of thromboembolic disease. A chest CT showed a mosaic pattern of lung attenuation, enlarged central pulmonary arteries, areas of ground-glass opacity, and mediastinal adenopathy. On the basis of these results the patient was given a presumptive diagnosis of PVOD. Chronic inhaled NO therapy was begun, and the patient is doing well 2 yr after discharge. A pulmonary venogram performed during this 2-yr period showed several sites of stenosis in the pulmonary veins. Balloon dilatation of several of these stenoses reduced the patient's dyspnea.
In this report we describe three patients with pulmonary hypertension and high-probability V˙/Q˙ scans resulting from PVOD. PVOD is a rare but increasingly recognized cause of pulmonary hypertension (6). The prognosis in PVOD is usually poor, with severe, progressive pulmonary hypertension and right ventricular failure usually occurring within 2 yr of diagnosis (7). Options for medical therapy other than lung transplantation have been disappointing. Intravenous epoprostenol, which has clear efficacy in primary pulmonary hypertension (PPH), has been reported to cause acute pulmonary edema and even death in patients with PVOD. Oral nifedipine, high-dose prostacyclin, inhaled NO, and aerosolized iloprost have been described as having beneficial hemodynamic effects in some patients (8-10). Distinguishing PVOD from both PPH and chronic thromboembolic disease, a surgically curable form of pulmonary hypertension (11, 12), is therefore critical.
Chest radiographic findings in PVOD include enlargement of the right side of the heart, dilated central pulmonary arteries, pleural effusions, and signs of pulmonary edema with bilateral increased interstitial markings and Kerley B lines (13, 14). Mediastinal adenopathy caused by vascular congestion may also be seen (15). Swensen and colleagues described common chest CT findings in eight patients with PVOD, which included smooth interlobular septal thickening, diffuse multifocal regions of ground-glass opacity, pleural effusions, a dilated main pulmonary artery and central pulmonary arteries, pulmonary veins of normal caliber, and a mosaic pattern of lung attenuation (16). Pulmonary angiography has been described as showing dilated patent pulmonary arteries, a prolonged circulation time, and a normal left atrium and pulmonary veins (13).
V˙/Q˙ lung scanning plays a pivotal role in the diagnostic approach to patients with pulmonary hypertension. In PPH (and other forms of small-vessel pulmonary hypertension), V˙/Q˙ scans are characteristically normal or may demonstrate a mottled appearance (17). In chronic thromboembolic pulmonary hypertension, segmental or larger perfusion defects are invariably present. In addition to thromboembolism, processes including pulmonary artery sarcoma, vasculitis, and extrinsic compression by mediastinal adenopathy or fibrosis will cause obstruction of segmental or larger arteries and lead to a high-probability V˙/Q˙ scan. Pulmonary angiography in these cases will confirm occlusion or extrinisic compression of the pulmonary arterial branches.
In PVOD, V˙/Q˙ scans are frequently reported to be normal (13). Other reported findings have included diffuse, patchy distribution of tracer material without clear segmental or subsegmental defects, and unilateral absence of perfusion due to severe asymmetric involvement of the major pulmonary veins (17-19). To our knowledge, this is the first report of multiple segmental mismatched perfusion defects with negative pulmonary angiograms in patients with PVOD.
In the third case, in which lung biopsy was not performed, the diagnosis of PVOD was initially suggested on clinical grounds. This patient's chest CT had several findings reported to be consistent with the diagnosis of PVOD, including a mosaic pattern of lung attenuation, enlarged central pulmonary arteries, areas of smooth interlobular septal thickening, and mediastinal adenopathy (16, 20). In addition, the pulmonary venogram demonstrated focal venous obstructions, a finding highly suggestive of the diagnosis of PVOD. The patient in this case has been treated with chronic inhaled NO for 2 yr, and has continued to do well.
Other potential causes of pulmonary venous obstruction that could result in the abnormalities observed in the V˙/Q˙ scan in the third case include extrinsic compression of the pulmonary veins or pulmonary capillary hemangiomatosis (PCH) (21). Although PCH could not be definitively ruled out in this case without histologic examination of lung tissue, extrinsic compression of the pulmonary veins was excluded by chest CT.
One hypothesis that could explain the discordance between the findings in the V˙/Q˙ scan and pulmonary angiogram in PVOD relates to the increased downstream resistance caused by the narrowing and obliteration of pulmonary veins and venules. Since the distribution of particles in the lungs is proportional to regional pulmonary blood flow, high downstream resistance could reduce tracer deposition in the precapillary arterioles upstream of the venous occlusion, resulting in a mismatched perfusion defect in the V˙/Q˙ scan. That these areas fail to demonstrate corresponding defects in the pulmonary angiogram could be explained by the higher pressure used in injecting contrast medium into the pulmonary arteries, which would overcome the increased downstream resistance.
Why some cases of PVOD show this V˙/Q˙ scan abnormality while others do not is unclear. Perhaps disease resulting in more extensive involvement of larger veins leads to segmental defects, whereas diffuse involvement of smaller venules produces the more frequently described V˙/Q˙ scan abnormality of diffuse patchy distribution of tracer material. This hypothesis is supported by the findings on pulmonary venography described in the third case, with extensive involvement of larger veins.
We found one report of unilateral absence of perfusion associated with stenosis involving the main pulmonary veins in PVOD (19). In contrast to our patients, this patient did not undergo pulmonary angiography, and pulmonary artery embolic disease could therefore not be excluded.
The findings in this report have important clinical implications. Systemic vasodilators such as prostacyclin have been reported to cause pulmonary edema and even death in patients with PVOD (22, 23). Therefore, a high index of suspicion for PVOD should be present when a discrepancy exists between the V˙/Q˙ scan and pulmonary angiogram.
In conclusion, a high-probability V˙/Q˙ scan in a patient with pulmonary hypertension does not always indicate a proximal pulmonary arterial process; when coupled with an angiogram showing no arterial obstruction, this finding is probably due to a focal “downstream” process such as PVOD.
The authors thank Eunhee S. Yi, M.D., of the Department of Pathology, University of California at San Diego Medical Center, for assistance with the pathologic material in the cases described in this report.
Supported in part by Pulmonary Training Grant 5T34HL0722-24 from the National Institutes of Health.
1. | Rubin LJApproach to the diagnosis and treatment of pulmonary hypertension. Chest961989659664 |
2. | McNeil BJA diagnostic strategy using ventilation-perfusion studies in patients suspect for pulmonary embolism. J Nucl Med171976613616 |
3. | Berry DF, Buccigrossi D, Peabody J, Peterson KL, Moser KMPulmonary vascular occlusion and fibrosing mediastinitis. Chest891986296301 |
4. | Myerson PJ, Myerson DA, Katz R, Lawson JPGallium imaging in pulmonary artery sarcoma mimicking pulmonary embolism: case report. J Nucl Med171976893895 |
5. | Kerr KM, Auger WR, Fedullo PF, Channick RN, Yi ES, Moser KMLarge vessel pulmonary arteritis mimicking chronic thromboembolic disease. Am J Respir Crit Care Med1521995367373 |
6. | Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK, et al.. Primary pulmonary hypertension: a national prospective study. Ann Intern Med1071987216223 |
7. | Pietra GG, Edwards WD, Kay JM, Rich S, Kernis J, Schloo B, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al.. Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, primary pulmonary hypertension registry. Circulation80198911981206 |
8. | Salzman GA, Rosa UWProlonged survival in pulmonary veno-occlusive disease treated with nifedipine. Chest95198911541156 |
9. | Davis LL, deBoisblanc BP, Glynn CE, Ramirez C, Summer WREffect of prostacyclin on microvascular pressures in a patient with pulmonary veno-occlusive disease. Chest108199517541756 |
10. | Hoeper MM, Eschenbruch C, Zink-Wohlfart C, Schulz A, Markworth S, Pohl K, Fabel HEffects of inhaled nitric oxide and aerosolized iloprost in pulmonary veno-occlusive disease. Respir Med9319996270 |
11. | Moser KM, Auger WR, Fedullo PF, Jamieson SWChronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J51992334342 |
12. | Rubin LJPrimary pulmonary hypertension. Chest1041993235250 |
13. | Scheibel R, Dedeker K, Gleason D, Pliego M, Kieffer SARadiographic and angiographic characteristics of pulmonary veno-occlusive disease. Radiology10319724751 |
14. | Wagenvoort CAPulmonary veno-occlusive disease: entity or syndrome? Chest6919768286 |
15. | Veeraraghavan S, Koss MN, Sharma OPPulmonary veno-occlusive disease. Curr Opin Pulm Med51999310313 |
16. | Swensen SJ, Tashjian JH, Myers JL, Engeler CE, Patz EF, Edwards WD, Douglas WWPulmonary venoocclusive disease. AJR Am J Roentgenol1671999937940 |
17. | Rich S, Giuseppe G, Pietra MD, Kieras K, Hart K, Brundage BHPrimary pulmonary hypertension: radiographic and scintigraphic patterns of histologic subtypes. Ann Intern Med1051986499502 |
18. | Sola M, Garcia A, Picado C, Ramirez J, Plaza V, Herranz RSegmental contour pattern in a case of pulmonary venoocclusive disease. Clin Nucl Med181993679681 |
19. | Calderon M, Burdine JAPulmonary veno-occlusive disease. J Nucl Med151973455457 |
20. | Dufour B, Maitre S, Humbert M, Capron F, Simonneau G, Musset DHigh-resolution CT of the chest in four patients with pulmonary capillary hemangiomatosis or pulmonary venoocclusive disease. AJR Am J Roentgenol171199813211324 |
21. | Tron V, Magee F, Wright JL, Colby T, Churg APulmonary capillary hemangiomatosis. Hum Pathol17198611441150 |
22. | Rubin LJ, Mendoza M, Hood M, McGoon M, Barst R, Williams W, Diehl JH, Crow J, Long WTreatment of pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial. Ann Intern Med1121990485491 |
23. | Palmer SM, Robinson LJ, Wang A, Gossage JR, Bashore T, Tapson VFMassive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest1131998237240 |